Methicillin
Staphcillin (methicillin) is a small molecule pharmaceutical. Methicillin was first approved as Staphcillin on 1982-01-01. It is used to treat gram-positive bacterial infections in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
infections | D007239 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Methicillin sodium
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
STAPHCILLIN | Bristol Myers Squibb | N-050117 DISCN | 1982-01-01 | 3 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
gram-positive bacterial infections | — | D016908 | — |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
1 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neurogenic urinary bladder | D001750 | HP_0000011 | N31 | 1 | — | — | — | — | 1 |
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | METHICILLIN |
INN | meticillin |
Description | Methicillin is a penicillin that is 6-aminopenicillanic acid in which one of the amino hydrogens is replaced by a 2,6-dimethoxybenzoyl group. It has a role as an antibacterial drug. It is a penicillin and a penicillin allergen. It is a conjugate acid of a methicillin(1-). |
Classification | Small molecule |
Drug class | penicillins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | COc1cccc(OC)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12 |
Identifiers
PDB | — |
CAS-ID | 61-32-5 |
RxCUI | 589822 |
ChEMBL ID | CHEMBL575 |
ChEBI ID | 6827 |
PubChem CID | 6087 |
DrugBank | DB01603 |
UNII ID | Q91FH1328A (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 79,562 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
25 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more